Fan J L, Himeno K, Hussain A, Nomoto K
Department of Immunology, Kyushu University, Fukuoka, Japan.
Biotherapy. 1989;1(2):97-102. doi: 10.1007/BF02170140.
MRL/Mp-lpr/lpr (MRL/1) mice spontaneously develop autoimmune diseases like systemic lupus erythematosus (SLE) from 2 months of age, accompanied by massive lymphadenopathy. Such mice of 2 months of age were treated with 1 microgram cholera toxin (CT) every 7 days and/or with 400 rad of one-shot 60Co irradiation. CT treatment alone markedly improved nephritis as evaluated by proteinuria and moderately suppressed lymphadenopathy and anti-DNA antibody production, while irradiation alone prominently improved lymphadenopathy but showed little effect on both nephritis and anti-DNA antibody production. On the other hand, when mice were treated with the combination of CT plus irradiation, autoimmune nephritis as well as anti-DNA production and lymphadenopathy were almost completely inhibited. Taken together, each agent exerts the improvement effect at the different points from each other in an abnormal immunological circuit displayed in MRL/1 mice. This kind of combined treatment may be applicable to the clinical use for autoimmune diseases.
MRL/Mp-lpr/lpr(MRL/1)小鼠从2月龄起会自发发展出自身免疫性疾病,如系统性红斑狼疮(SLE),并伴有大量淋巴结病。对2月龄的此类小鼠每7天用1微克霍乱毒素(CT)进行治疗和/或进行单次400拉德的60Co照射。单独使用CT治疗可显著改善蛋白尿评估的肾炎,并适度抑制淋巴结病和抗DNA抗体的产生,而单独照射可显著改善淋巴结病,但对肾炎和抗DNA抗体的产生几乎没有影响。另一方面,当小鼠接受CT加照射的联合治疗时,自身免疫性肾炎以及抗DNA产生和淋巴结病几乎完全受到抑制。综上所述,在MRL/1小鼠显示的异常免疫回路中,每种药物在彼此不同的点发挥改善作用。这种联合治疗可能适用于自身免疫性疾病的临床应用。